Research Article
Predictors of Treatment with Duloxetine or Venlafaxine XR among Adult Patients Treated for Depression in Primary Care Practices in the United Kingdom
Table 1
Demographic characteristics of patients Initiating duloxetine or venlafaxine XR.
| | Duloxetine | Venlafaxine XR | value | | /mean | %/SD | /mean | %/SD |
| Number of patients () | 909 | | 1,286 | | | Female (, %) | 615 | 67.7% | 829 | 64.5% | 0.120 | Age (, %) | | | | | <0.001 | 18–34 | 177 | 19.5% | 345 | 26.8% | <0.001 | 35–44 | 206 | 22.7% | 333 | 25.9% | 0.083 | 45–54 | 194 | 21.3% | 254 | 19.8% | 0.362 | 55–64 | 156 | 17.2% | 193 | 15.0% | 0.174 | 65+ | 176 | 19.4% | 161 | 12.5% | <0.001 | Age (mean, SD) | 49.6 | 16.5 | 45.5 | 16.1 | <0.001 |
|
|